CNCR Loncar癌症免疫疗法ETF基金
开盘价
市值
最高价
最低价
收盘价
成交量
市盈率
股息率
CNCR Loncar癌症免疫疗法ETF基金简介
本基金所追踪之指数为Range Cancer Therapeutics Index，在扣除各种费用和支出之前追求达到和指数一样的投资表现。本基金试图将其全部或绝大部分资产投资于构成该指数的成分证券和ADR。在正常情况下，至少80%的基金总资产（不包括因证券借贷而持有的任何抵押品）将投资于指数的成分证券。
如何购买 CNCR Loncar癌症免疫疗法ETF基金 (CNCR)
登录
1分钟开户
仅需1分钟即可完成账户申请和验证。整个过程完全自助，支持 RockFlow App 和网页端操作。
充值资金
账户验证完成后，您可以使用首选的支付方式向账户充值。
购买 CNCR
通过 RockFlow App 或网页端搜索 CNCR，输入您想要投资的金额，然后点击确认即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.